Search research articles
Contact Us
Filters
Showing results (31-40 of 45) with videos related to
Page
of 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2019
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 5, 2022
<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, et al.
The Lancet. Oncology
|
February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
Heying Duan, Farshad Moradi, Guido A Davidzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2022
A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
Heying Duan, Pejman Ghanouni, Bruce Daniel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Clément Morgat, Heying Duan, Simone Dalm, et al.
Molecular Imaging
|
September 8, 2022
Biodistribution of a Mitochondrial Metabolic Tracer, [<sup>18</sup>F]F-AraG, in Healthy Volunteers
Jelena Levi, Heying Duan, Shahriar Yaghoubi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 9, 2014
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function
Thomas Scherer, Peter Wolf, Yvonne Winhofer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
Lucia Baratto, Hong Song, Heying Duan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 24, 2025
Localization of sentinel lymph nodes using augmented-reality system: a cadaveric feasibility study
Heying Duan, Yue Yang, Wally L Niu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 3, 2021
Pilot-phase PET/CT study targeting integrin α<sub>v</sub>β<sub>6</sub> in pancreatic cancer patients using the cystine-knot peptide-based <sup>18</sup>F-FP-R<sub>0</sub>1-MG-F2
Ryusuke Nakamoto, Valentina Ferri, Heying Duan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 45) with videos related to
Sort By:
Page
of 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 20, 2019
Prospective Evaluation of <sup>18</sup>F-DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer in an Academic Center: A Focus on Disease Localization and Changes in Management
Hong Song, Caitlyn Harrison, Heying Duan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 5, 2022
<sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
Farshad Moradi, Heying Duan, Hong Song, et al.
The Lancet. Oncology
|
February 29, 2024
<sup>68</sup>Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial
Heying Duan, Farshad Moradi, Guido A Davidzon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2022
A Pilot Study of <sup>68</sup>Ga-PSMA11 and <sup>68</sup>Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
Heying Duan, Pejman Ghanouni, Bruce Daniel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry
Clément Morgat, Heying Duan, Simone Dalm, et al.
Molecular Imaging
|
September 8, 2022
Biodistribution of a Mitochondrial Metabolic Tracer, [<sup>18</sup>F]F-AraG, in Healthy Volunteers
Jelena Levi, Heying Duan, Shahriar Yaghoubi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 9, 2014
Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function
Thomas Scherer, Peter Wolf, Yvonne Winhofer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 6, 2021
PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer
Lucia Baratto, Hong Song, Heying Duan, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 24, 2025
Localization of sentinel lymph nodes using augmented-reality system: a cadaveric feasibility study
Heying Duan, Yue Yang, Wally L Niu, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 3, 2021
Pilot-phase PET/CT study targeting integrin α<sub>v</sub>β<sub>6</sub> in pancreatic cancer patients using the cystine-knot peptide-based <sup>18</sup>F-FP-R<sub>0</sub>1-MG-F2
Ryusuke Nakamoto, Valentina Ferri, Heying Duan, et al.
Page
of 5